Reference Source

General Factory of Beijing Zhangguang Hair Regrowth Liniment · 66-41 · CHINA

For General Factory of Beijing Zhangguang Hair Regrowth Liniment, import alert is 66-41; country is CHINA; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; product is Hair Regrowth Liniment (AKA Formula 101); product code is 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 09/30/2009; address is 725 Area 7 Jim Song Xi , Chagyang, Beijing CHINA, verified against its source on 2026-10-01.

Firm
General Factory of Beijing Zhangguang Hair Regrowth Liniment verified
Import alert
66-41
Import alert name
Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
Country
CHINA verified
Address
725 Area 7 Jim Song Xi , Chagyang, Beijing CHINA verified
Date published
09/30/2009 verified
Product code
66 V - - 99 Miscellaneous Patent Medicines, Etc. verified
Product
Hair Regrowth Liniment (AKA Formula 101) verified
Sourceaccessdata.fda.gov
Verified
Review by
DatasetFDA import alert red lists: firms subject to detention without physical examination

What the source says

General Factory of Beijing Zhangguang Hair Regrowth Liniment Date Published : 09/30/2009 725 Area 7 Jim Song Xi , Chagyang, Beijing CHINA

— accessdata.fda.gov, retrieved 2026-09-15

Where each value comes from

The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.

Product code and Product

66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 11/27/2019 Desc: Hair Regrowth Liniment (AKA Formula 101)

— all from accessdata.fda.gov, retrieved 2026-09-15

Source

Last verified against source: . Due for re-check by . This page as Markdown · OKF bundle · full dataset as JSON.

This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.